Redeye: Azelio - Azelio - New Guidance – New Projections
19 maj, 2022
19 maj, 2022
Redeye resumes coverage of Azelio following its introduction of new operational targets for the coming years. Most notably, the targets are now related to making deals rather than establishing a production capacity. However, the targets imply a substantially slower commercial scale-up than we previously expected. We make significant changes to our estimates, resulting in a lower fair value range
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
Azelio - New Guidance – New Projections
19 maj, 2022
Redeye resumes coverage of Azelio following its introduction of new operational targets for the coming years. Most notably, the targets are now related to making deals rather than establishing a production capacity. However, the targets imply a substantially slower commercial scale-up than we previously expected. We make significant changes to our estimates, resulting in a lower fair value range
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments
Azelio - New Guidance – New Projections
Rapportperioden
Plejd
Inflationen
Rapportperioden
Plejd
Inflationen
1 DAG %
Senast
sbab
Idag, 10:15
SBAB:s krympande intäkter
OMX Stockholm 30
1 DAG %
Senast
2 524,33